Skip to main content
Equibles

Rick Winningham

Board Member

Theravance Biopharma, Inc.

CEO

Theravance Biopharma, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Rick Winningham

Rick Winningham is recorded as Board Member and CEO at Theravance Biopharma, Inc.. Rick Winningham has spoken on 23 earnings calls across 1 company, most recently for Theravance Biopharma, Inc. on November 10, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Theravance Biopharma, Inc.

    Board Member

    Proxy statement

    Current

    Start not stated–present

  • Theravance Biopharma, Inc.

    CEO

    Proxy statement

    Current

    Start not stated–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Theravance Biopharma, Inc.

Current role

Board Member, CEO

23 appearances Latest appearance 2025-11-10

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2025 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2025 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2025 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2024 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2023 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2022 Earnings Call

    Theravance Biopharma, Inc.

Show 11 earlier activities
  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2022 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2022 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2022 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2021 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2021 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2021 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2021 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q4 FY2020 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q3 FY2020 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q2 FY2020 Earnings Call

    Theravance Biopharma, Inc.

  • Earnings call

    Theravance Biopharma, Inc. Q1 FY2020 Earnings Call

    Theravance Biopharma, Inc.